lancet
respiratori
medicin
kollengod
ramanathan
colleagu
provid
excel
recommend
use
extracorpor
membran
oxygen
ecmo
patient
respiratori
failur
acut
respiratori
distress
syndrom
ard
secondari
coronaviru
diseas
author
describ
pragmat
approach
challeng
deliv
ecmo
patient
includ
train
healthcar
personnel
resolv
equip
facil
issu
implement
system
infect
control
person
protect
provid
overal
support
healthcar
staff
mitig
ethic
issu
also
address
anticip
challeng
local
region
surg
ard
case
although
increas
hospit
capac
provid
ecmo
potenti
demand
might
exceed
avail
resourc
furthermor
healthcar
system
offer
advanc
therapi
ecmo
lack
coordin
local
region
nation
referr
protocol
given
practic
constraint
substanti
increas
global
avail
ecmo
servic
next
month
import
emphasis
evidencebas
treatment
option
provid
patient
sever
ard
figur
endotrach
intub
import
consid
trial
highflow
nasal
oxygen
patient
moder
sever
hypoxaemia
procedur
might
avoid
need
intub
mechan
ventil
provid
high
concentr
humidifi
oxygen
low
level
posit
endexpiratori
pressur
facilit
elimin
carbon
dioxid
guidelin
support
use
highflow
nasal
oxygen
patient
urg
close
monitor
clinic
deterior
could
result
need
emerg
intub
procedur
might
increas
risk
infect
healthcar
worker
patient
requir
endotrach
intub
use
low
tidal
volum
mlkg
per
predict
bodyweight
plateau
airway
pressur
less
cm
h
increas
respiratori
rate
breath
per
min
need
mainstay
lungprotect
ventil
hypoxaemia
progress
pao
fio
ratio
less
mm
hg
sever
therapeut
option
level
posit
endexpiratori
pressur
increas
cm
h
everi
min
improv
oxygen
satur
goal
maintain
plateau
airway
pressur
less
cm
h
lower
drive
pressur
plateau
airway
pressur
minu
posit
endexpiratori
pressur
target
cm
h
also
use
patient
respond
adjust
level
posit
endexpiratori
pressur
addit
strategi
might
stabilis
recruit
manoeuvr
probabl
littl
valu
prone
posit
institut
unless
specif
contraind
initi
along
intervent
alreadi
describ
persist
refractori
hypoxaemia
even
prone
posit
neuromuscular
blockad
effort
optimis
posit
endexpiratori
pressur
therapi
addit
option
inhal
ppm
might
improv
oxygen
insert
oesophag
balloon
measur
transpulmonari
pressur
set
optim
posit
endexpiratori
pressur
consid
patient
moderatetosever
obes
although
trial
patient
ard
show
benefit
procedur
patient
fluid
manag
import
consid
measur
reduc
pulmonari
oedema
absenc
shock
fluid
conserv
therapi
recommend
achiev
neg
fluid
balanc
l
per
day
presenc
shock
fluid
balanc
might
achiev
renal
replac
therapi
especi
associ
acut
kidney
injuri
oliguria
antibiot
consid
sinc
secondari
bacteri
infect
report
patient
glucocorticoid
avoid
view
evid
harm
case
viral
pneumonia
ard
influenza
rescu
therapi
highdos
vitamin
c
also
consid
final
ecmo
consid
use
inclus
exclus
criteria
eolia
trial
sinc
treatment
sever
ard
ongo
challeng
import
learn
patient
treat
gain
understand
diseas
epidemiolog
biolog
mechan
effect
new
pharmacolog
intervent
current
research
group
work
coordin
dissemin
key
inform
includ
inform
patient
treat
ecmo
although
accur
estim
number
patient
current
avail
extracorpor
life
support
organ
intern
nonprofit
consortium
plan
maintain
registri
patient
facilit
improv
understand
ecmo
use
patient
mam
report
grant
nation
institut
healthth
nation
heart
lung
blood
institut
us
food
drug
administr
us
depart
defens
bayer
pharmaceut
genentechroch
person
fee
life
scienc
outsid
submit
work
jma
done
part
electron
medic
record
committe
societi
critic
care
medicin
outsid
submit
work
jeg
declar
compet
interest
